Research ArticleArticle
Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs?
Elena Ciubotariu, Cem Gabay and Axel Finckh Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis
The Journal of Rheumatology July 2014, jrheum.130767; DOI: https://doi.org/10.3899/jrheum.130767
Elena Ciubotariu
From the Division of Rheumatology, University Hospital Sacré Coeur de Montréal, Montréal, Canada; Division of Rheumatology, University Hospital of Geneva; and Division of Clinical Epidemiology, University Hospital of Geneva, Geneva, Switzerland. E. Ciubotariu is supported by research grants from Montréal University and AMRQ (Association des Médecins Rhumatologues du Québec). A. Finckh is supported by a research grant from the Geneva University and the Swiss National Science Foundation (Grant No. 3200B0-120639). C. Gabay is supported by the Swiss National Science Foundation (Grant No. 310030-135195). E. Ciubotariu, MD, MSc, Division of Rheumatology, University Hospital Sacré Coeur of Montréal; C. Gabay, MD, PhD, Professor, Division of Rheumatology, University Hospital of Geneva; A. Finckh, MD, PhD, Adjoint Professor Division of Rheumatology; Division of Clinical Epidemiology, University Hospital of Geneva. Address correspondence to Drs. Ciubotariu and Finckh, Division of Rheumatology, Department of Internal Medicine, University Hospital of Geneva, 26 Av. Beau-Sejour, 1211 Geneva 14. E-mail: ileana.ciubotariu@gmail.com, axel.finckh@hcuge.ch. Accepted for publication February 20, 2014.
Cem Gabay
From the Division of Rheumatology, University Hospital Sacré Coeur de Montréal, Montréal, Canada; Division of Rheumatology, University Hospital of Geneva; and Division of Clinical Epidemiology, University Hospital of Geneva, Geneva, Switzerland. E. Ciubotariu is supported by research grants from Montréal University and AMRQ (Association des Médecins Rhumatologues du Québec). A. Finckh is supported by a research grant from the Geneva University and the Swiss National Science Foundation (Grant No. 3200B0-120639). C. Gabay is supported by the Swiss National Science Foundation (Grant No. 310030-135195). E. Ciubotariu, MD, MSc, Division of Rheumatology, University Hospital Sacré Coeur of Montréal; C. Gabay, MD, PhD, Professor, Division of Rheumatology, University Hospital of Geneva; A. Finckh, MD, PhD, Adjoint Professor Division of Rheumatology; Division of Clinical Epidemiology, University Hospital of Geneva. Address correspondence to Drs. Ciubotariu and Finckh, Division of Rheumatology, Department of Internal Medicine, University Hospital of Geneva, 26 Av. Beau-Sejour, 1211 Geneva 14. E-mail: ileana.ciubotariu@gmail.com, axel.finckh@hcuge.ch. Accepted for publication February 20, 2014.
Axel Finckh
From the Division of Rheumatology, University Hospital Sacré Coeur de Montréal, Montréal, Canada; Division of Rheumatology, University Hospital of Geneva; and Division of Clinical Epidemiology, University Hospital of Geneva, Geneva, Switzerland. E. Ciubotariu is supported by research grants from Montréal University and AMRQ (Association des Médecins Rhumatologues du Québec). A. Finckh is supported by a research grant from the Geneva University and the Swiss National Science Foundation (Grant No. 3200B0-120639). C. Gabay is supported by the Swiss National Science Foundation (Grant No. 310030-135195). E. Ciubotariu, MD, MSc, Division of Rheumatology, University Hospital Sacré Coeur of Montréal; C. Gabay, MD, PhD, Professor, Division of Rheumatology, University Hospital of Geneva; A. Finckh, MD, PhD, Adjoint Professor Division of Rheumatology; Division of Clinical Epidemiology, University Hospital of Geneva. Address correspondence to Drs. Ciubotariu and Finckh, Division of Rheumatology, Department of Internal Medicine, University Hospital of Geneva, 26 Av. Beau-Sejour, 1211 Geneva 14. E-mail: ileana.ciubotariu@gmail.com, axel.finckh@hcuge.ch. Accepted for publication February 20, 2014.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs?
Elena Ciubotariu, Cem Gabay, Axel Finckh
The Journal of Rheumatology Jul 2014, jrheum.130767; DOI: 10.3899/jrheum.130767